Drug Discovery

DiscoverBMB is the annual meeting of the American Society for Biochemistry and Molecular Biology. With a mission to share the latest, most impactful research findings in the molecular life sciences, DiscoverBMB offers an exciting agenda that includes talks by the field’s foremost experts, interactive workshops on the latest trends, technologies and techniques, and an invigorating exhibition of posters, services and products. The meeting attracts researchers in academia and industry, educators, trainees and students from across the globe. It offers unparalleled opportunities for collaborating, networking and recruiting.

Where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge.

Explore the latest advancements in phenotypic and target-based discovery, chemical biology as well as drug design at our two-day summit. The event will bring together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimzation. A plethora of interactive panel and roundtable discussions, with ample networking opportunities to meet and discuss with world leading drug discovery experts.

As newly published data show the first Gamma Delta T cell therapy’s clinical efficacy in patients, the race to market for the first allogeneic and solid tumor-targeting γδT has begun. Join us at the 3rd Gamma Delta T Therapies Summit alongside 120+ of the world’s leaders in the field to discuss discovery to manufacturing and clinical development of these ‘holy grail’ therapies in allogeneic and solid tumor settings. Developed with key opinion leaders such as Adrian Hayday, and experts from Adicet Bio, Lava Therapeutics, IN8 Bio, and many more, attend this meeting to engage in interactive discussions and gain the actionable insights to advance bench to commercial bedside development of γδT-based therapies. Gather in person for the very first time with industry pioneers harnessing GDT cells to bring to market more cytotoxic, clinically safe therapies for solid tumors. From modulating cell activity through genetic engineering and antibody engagement to enhancing the functionality of GDT cells through an improved understanding of their intrinsic biology, this is a conversation you won’t want to miss.

Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from industry, academia and the FDA at 3 Conference Programs, Symposium, Training Seminar, Workshop and 5 Short Courses. Once again, we’ll host interactive breakouts on various niche topics so delegates can share experiences and generate new ideas. 

Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s interests by going back and forth among concurrent tracks.

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

BIO attracts leading biotechs, top 25 pharma, top 20 CROs and CMOs and major research labs and government agencies. The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. The conference brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.

The Alzheimer’s Association International Conference (AAIC®) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease. AAIC attracts the leading Physicians, Researchers, Scientists, Lab Managers and other allied health professionals involved in the Dementia & Neuroscience Markets.